| 71 |
Musculoskeletal ultrasound; the third eye of the rheumatologist. |
2018 |
| 72 |
Response of Chronic myeloid leukemia’s patient to different types of tyrosine kinase inhibitors |
2018 |
| 73 |
Study of the osteoprotegerin/receptor activator of nuclear factor-kB ligand system association with inflammation and atherosclerosis in systemic sclerosis |
2018 |
| 74 |
Survival outcomes of CD34+CD38−LSCs and their expression of
CD123 in adult AML patients |
2018 |
| 75 |
Telomere dysfunction-related serological markers and oxidative stress markers in rheumatoid arthritis patients: correlation with diseases activity |
2018 |
| 76 |
الخلايا السرطانية الدوارة (CTCs) كمؤشر حيوي في حالات سرطان الثدي الغير منتشر |
2018 |
| 77 |
الخلايا السرطانية الدوارة (CTCs) كمؤشر حيوي في حالات سرطان الثدي الغير منتشر |
2018 |
| 78 |
الخلايا السرطانية الدوارة (CTCs) كمؤشر حيوي في حالات سرطان الثدي الغير منتشر |
2018 |
| 79 |
Brain SPECT/CT scanning with technetium-99m pentavalent dimercaptosuccinic acid [DMSA (V)] is an accurate tool for post-treatment evaluation of patients with glioma. |
2017 |
| 80 |
Brain SPECT/CT scanning with technetium-99m pentavalent dimercaptosuccinic acid [DMSA (V)] is an accurate tool for post-treatment evaluation of patients with glioma. |
2017 |
هل لديك سؤال ؟
